Cryoprotectants for the vitrification of corneal endothelial cells.

Cryobiology

Department of Engineering Science, Oxford University, Parks Road, Oxford OX1 3PJ, UK.

Published: February 2009

The objective of this work was to select and test systematically possible cryoprotective agents (CPAs) and to obtain a suitable formula for vitrification of corneal endothelial cells (CECs). Fresh bovine CECs were isolated and tested with an optimized vitrification protocol with multi-step CPA loading and removal. Three types of CPAs components, i.e. the penetrating CPAs, sugars and macromolecular compounds, were experimentally evaluated using the viability assayed by trypan blue. Dimethyl sulfoxide, ethylene glycol (EG), 1,2-propanediol, 2,3-butanediol, acetamide and ethylene glycol monomethyl ether were chosen as the penetrating CPA components. Sugars including xylose, fructose, mannose, glucose, maltose, sucrose and trehalose were tested. Ficoll (MW 7kDa), dextran (MW 7kDa), chondroitin sulfate (CS, MW 18-30kDa), bovine serum albumin (MW 68kDa) and polyethylene glycol (MW 6kDa, 10kDa and 20kDa) were chosen as the macromolecular compounds. CECs were also preserved by slow freezing as a control. The results showed that EG was the most suitable penetrating CPA component and glucose the most suitable sugar, and CS the most suitable macromolecule. The optimized concentrations for each component in the vitrification solution were 52% (w/w) EG, 8% (w/w) glucose and 3% (w/w) CS. The CEC survival rate of 89.4+/-2.1% (mean+/-SD) was obtained using this formula and established vitrification protocol which was comparable to that by slow freezing.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cryobiol.2008.10.124DOI Listing

Publication Analysis

Top Keywords

vitrification corneal
8
corneal endothelial
8
endothelial cells
8
vitrification protocol
8
macromolecular compounds
8
ethylene glycol
8
penetrating cpa
8
slow freezing
8
cryoprotectants vitrification
4
cells objective
4

Similar Publications

Arrested Phase Separation Enables High-Performance Keratoprostheses.

Adv Mater

April 2023

School of Chemical Engineering and Light Industry, Gangdong University of Technology, Guangzhou, 510006, P. R. China.

Corneal transplantation is impeded by donor shortages, immune rejection, and ethical reservations. Pre-made cornea prostheses (keratoprostheses) offer a proven option to alleviate these issues. Ideal keratoprostheses must possess optical clarity and mechanical robustness, but also high permeability, processability, and recyclability.

View Article and Find Full Text PDF

Customizable Collagen Vitrigel Membranes and Preliminary Results in Corneal Engineering.

Polymers (Basel)

August 2022

Tecnologico de Monterrey, Escuela de Medicina, 3000 Morones Prieto Ave., Colonia Los Doctores. C.P., 64710 Monterrey, NL, Mexico.

Corneal opacities are a leading cause of visual impairment that affect 4.2 million people annually. The current treatment is corneal transplantation, which is limited by tissue donor shortages.

View Article and Find Full Text PDF

Analysis of Cryopreservation Protocols and Their Harmful Effects on the Endothelial Integrity of Human Corneas.

Int J Mol Sci

November 2021

Grupo de Investigación en Terapia Celular e Medicina Rexenerativa, Departamento de Fisioterapia, Medicina e Ciencias Biomédicas, Facultade de Ciencias da Saúde, Universidade da Coruña (UDC), Campus de Oza, 15006 A Coruña, Spain.

Corneal cryopreservation can partially solve the worldwide concern regarding donor cornea shortage for keratoplasties. In this study, human corneas were cryopreserved using two standard cryopreservation protocols that are employed in the Tissue Bank of the Teresa Herrera Hospital (Spain) to store corneas for tectonic keratoplasties (TK protocol) and aortic valves (AV protocol), and two vitrification protocols, VS55 and DP6. Endothelial viability and general corneal state were evaluated to determine the protocol that provides the best results.

View Article and Find Full Text PDF

Development, structure, and bioengineering of the human corneal stroma: A review of collagen-based implants.

Exp Eye Res

November 2020

Institut de la Vision, Sorbonne Université, INSERM, CNRS, Centre Hospitalier, National d'Ophtalmologie des 15-20, 75571, Paris, France; Groupe de Recherche Clinique 32, Sorbonne Université, Paris, France. Electronic address:

Bio-engineering technologies are currently used to produce biomimetic artificial corneas that should present structural, chemical, optical, and biomechanical properties close to the native tissue. These properties are mainly supported by the corneal stroma which accounts for 90% of corneal thickness and is mainly made of collagen type I. The stromal collagen fibrils are arranged in lamellae that have a plywood-like organization.

View Article and Find Full Text PDF

Multifunctional synthetic Bowman's membrane-stromal biomimetic for corneal reconstruction.

Biomaterials

May 2020

Translational Tissue Engineering Center, Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, MD, USA. Electronic address:

As the outermost layer of the eye, the cornea is vulnerable to physical and chemical trauma, which can result in loss of transparency and lead to corneal blindness. Given the global corneal donor shortage, there is an unmet need for biocompatible corneal substitutes that have high transparency, mechanical integrity and regenerative potentials. Herein we engineered a dual-layered collagen vitrigel containing biomimetic synthetic Bowman's membrane (sBM) and stromal layer (sSL).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!